The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Subcutaneous Drug Delivery Devices Market Expected To Change Between 2026 And 2030?
The market size for subcutaneous drug delivery devices has experienced substantial growth in recent years. This market is projected to expand from $29.77 billion in 2025 to $32.03 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be ascribed to several factors, including the increasing incidence of diabetes and chronic diseases, the wider adoption of insulin pens and pen needles, the expansion of hospital and clinic infrastructure, the restricted availability of advanced delivery technologies, and enhanced awareness regarding subcutaneous drug administration.
The subcutaneous drug delivery devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $42.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the forecast period include the expanding use of biologics and oncology treatments, the wider uptake of smart auto-injectors, the broadening of homecare environments, advancements in implantable pump technology, and a growing call for patient-focused drug delivery options. Key trends expected over the forecast period encompass the increasing use of auto-injectors and intelligent injection devices, a rising inclination towards therapies administered at home and by patients themselves, an escalating need for drug delivery techniques that are less invasive, the widening scope of biologic and biosimilar drug delivery applications, and enhanced patient adherence facilitated by intuitive device designs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp
What Drivers Are Expected To Influence The Subcutaneous Drug Delivery Devices Market During The Forecast Period?
The rising incidence of diabetes and cardiovascular diseases (CVD) is anticipated to fuel expansion in the subcutaneous drug delivery devices market. This escalating occurrence of diabetes and cardiovascular diseases stems from factors such as aging populations, poor dietary habits, inactive lifestyles, obesity, disparities in socioeconomic status, psychological stress, environmental influences, and restricted availability of preventive healthcare. These devices play a crucial role in diabetes management, facilitating the administration of insulin and other medications for blood sugar regulation, and in cardiovascular diseases, delivering drugs like anticoagulants or lipid-lowering agents, thereby offering an efficient and regulated approach to addressing these long-term ailments. A case in point is the statistic reported in October 2024 by the Centers for Disease Control and Prevention, a US-based federal agency, which indicated that in 2023, 919,032 individuals succumbed to cardiovascular disease, representing 1 in every 3 deaths. Consequently, the growing prevalence of diabetes and cardiovascular diseases (CVD) is significantly contributing to the expansion of the subcutaneous drug delivery devices market.
How Is The Subcutaneous Drug Delivery Devices Market Structured Across Different Segments?
The subcutaneous drug delivery devices market covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) By Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) By Pen Needles: Standard Pen Needles, Safety Pen Needles
3) By Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) By Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) By Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
Which Trends Are Shaping The Future Of The Subcutaneous Drug Delivery Devices Market?
Leading companies in the subcutaneous drug delivery devices market are concentrating on developing innovative products, such as miniature digital liquid flow sensors. This focus aims to improve the safety and precision of subcutaneous drug delivery by supplying accurate, customizable flow sensors for large-volume injectors. Miniature digital liquid flow sensors are compact instruments that accurately measure the flow rate of liquids in small-scale applications, providing digital output for precise monitoring and control. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, launched the SLD3x series sensor platform. This sensor series includes highly accurate digital liquid flow sensors with customizable solutions, enabling precise flow measurement, occlusion detection, in-line air bubble identification, and liquid temperature monitoring. These miniature sensors are perfectly suited for large-scale medical device manufacturing, guaranteeing optimal dosing and elevated patient safety in subcutaneous drug delivery.
Which Major Players Dominate The Subcutaneous Drug Delivery Devices Market?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
Read the full subcutaneous drug delivery devices market report here:
Which Region Is Forecast To Lead The Subcutaneous Drug Delivery Devices Market In Terms Of Market Size?
North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Subcutaneous Drug Delivery Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19723&type=smp
Browse Through More Reports Similar to the Global Subcutaneous Drug Delivery Devices Market 2026, By The Business Research Company
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Implantable Drug Delivery Devices Market Report 2026
Liposomal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model